Raleigh Capital Management Inc. Has $55,000 Stock Position in Aflac Incorporated (NYSE:AFL)

Raleigh Capital Management Inc. boosted its stake in shares of Aflac Incorporated (NYSE:AFLFree Report) by 23.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 531 shares of the financial services provider’s stock after buying an additional 100 shares during the period. Raleigh Capital Management Inc.’s holdings in Aflac were worth $55,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of AFL. Darwin Wealth Management LLC acquired a new stake in shares of Aflac during the third quarter valued at approximately $34,000. Raelipskie Partnership purchased a new position in Aflac during the 3rd quarter worth approximately $38,000. Covestor Ltd raised its stake in Aflac by 41.8% during the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock valued at $41,000 after purchasing an additional 107 shares during the period. Kennebec Savings Bank purchased a new stake in shares of Aflac in the third quarter valued at $45,000. Finally, Catalyst Capital Advisors LLC acquired a new stake in shares of Aflac in the third quarter worth $51,000. 67.44% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, EVP Audrey B. Tillman sold 24,744 shares of the business’s stock in a transaction dated Friday, December 27th. The stock was sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the transaction, the executive vice president now owns 222,618 shares of the company’s stock, valued at approximately $23,018,701.20. The trade was a 10.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.90% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research analysts recently weighed in on AFL shares. Keefe, Bruyette & Woods dropped their price target on Aflac from $108.00 to $107.00 and set a “market perform” rating on the stock in a research report on Friday, January 10th. Evercore ISI dropped their target price on Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a report on Wednesday, December 4th. TD Cowen assumed coverage on shares of Aflac in a report on Wednesday, October 9th. They set a “hold” rating and a $102.00 price target for the company. Piper Sandler upped their price objective on shares of Aflac from $114.00 to $122.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. Finally, BMO Capital Markets initiated coverage on shares of Aflac in a research report on Thursday. They issued a “market perform” rating and a $111.00 target price for the company. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, Aflac has an average rating of “Hold” and an average price target of $102.67.

Check Out Our Latest Stock Analysis on Aflac

Aflac Trading Up 0.1 %

Aflac stock opened at $104.43 on Friday. Aflac Incorporated has a one year low of $75.07 and a one year high of $115.50. The company’s fifty day moving average price is $106.12 and its two-hundred day moving average price is $105.71. The company has a market capitalization of $58.02 billion, a price-to-earnings ratio of 15.73, a PEG ratio of 2.13 and a beta of 1.00. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.08 and a quick ratio of 0.08.

Aflac (NYSE:AFLGet Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share for the quarter, beating analysts’ consensus estimates of $1.69 by $0.47. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The business had revenue of $2.95 billion for the quarter, compared to the consensus estimate of $4.30 billion. During the same period last year, the business earned $1.84 EPS. The firm’s revenue was down 40.4% compared to the same quarter last year. On average, analysts forecast that Aflac Incorporated will post 7.26 earnings per share for the current fiscal year.

Aflac Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Stockholders of record on Wednesday, February 19th will be paid a $0.58 dividend. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.22%. This is a boost from Aflac’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Wednesday, February 19th. Aflac’s payout ratio is presently 30.12%.

Aflac Company Profile

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

See Also

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFLFree Report).

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.